K A Newell, L C Cendales, A D Kirk. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » AlemtuzumabAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntibodies, Neoplasm/therapeutic useGraft Rejection/drug therapyGraft Rejection/prevention & controlHumansImmunosuppressive Agents/therapeutic useKidney Transplantation
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, NeoplasmImmunosuppressive AgentsAlemtuzumab
Year: 2008 PMID: 18557735 DOI: 10.1111/j.1600-6143.2008.02291.x
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 8.086